Clinical Trial Update: Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for benralizumab in severe eosinophilic asthma, focusing on airway remodeling. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 4 | Status: ACTIVE_NOT_RECRUITING